PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,680,000 | +1082.6% | 310,000 | +1348.6% | 0.00% | – |
| Q4 2021 | $734,000 | +90.6% | 21,400 | -1.9% | 0.00% | – |
| Q3 2021 | $385,000 | -86.5% | 21,805 | -66.1% | 0.00% | -100.0% |
| Q2 2021 | $2,844,000 | +18.3% | 64,280 | -28.6% | 0.00% | -50.0% |
| Q1 2021 | $2,404,000 | -12.7% | 90,073 | -32.6% | 0.00% | 0.0% |
| Q4 2020 | $2,755,000 | +9083.3% | 133,574 | +9407.0% | 0.00% | – |
| Q3 2020 | $30,000 | -6.2% | 1,405 | -22.2% | 0.00% | – |
| Q2 2020 | $32,000 | +700.0% | 1,805 | +196.4% | 0.00% | – |
| Q1 2020 | $4,000 | -78.9% | 609 | -78.2% | 0.00% | – |
| Q4 2019 | $19,000 | -24.0% | 2,794 | +35.0% | 0.00% | – |
| Q3 2019 | $25,000 | -26.5% | 2,070 | -26.7% | 0.00% | – |
| Q2 2019 | $34,000 | -75.5% | 2,823 | -74.4% | 0.00% | – |
| Q1 2019 | $139,000 | +3375.0% | 11,026 | +1675.5% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 621 | +0.5% | 0.00% | – |
| Q3 2018 | $6,000 | +50.0% | 618 | +1.5% | 0.00% | – |
| Q2 2018 | $4,000 | -60.0% | 609 | -45.8% | 0.00% | – |
| Q1 2018 | $10,000 | -91.9% | 1,123 | -81.1% | 0.00% | – |
| Q4 2017 | $123,000 | +1266.7% | 5,930 | +1086.0% | 0.00% | – |
| Q3 2017 | $9,000 | +50.0% | 500 | -4.6% | 0.00% | – |
| Q2 2017 | $6,000 | – | 524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |